Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Fig 6

Research Article

NBM-HD-1: A Novel Histone Deacetylase Inhibitor with Anticancer Activity

Figure 6

NBM-HD-1 inhibits tumor growth in vivo after intraperitoneal (i.p.) administration. Nude mice were injected subcutaneously with MDA-MB-231 cells ( per mouse). NBM-HD-1 was i.p. injected daily for 35 days. (a) The surgical tumors. (b) Tumor weights were measured after the mice were sacrificed. Student’s -test was used to calculate the statistical significance of differences between each group and the control group. Data are shown as the mean ± SD. ** versus the control.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.